VANGUARD GROUP INC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$367,270,076
-23.1%
8,903,517
+4.2%
0.01%
-18.2%
Q2 2023$477,353,601
-2.6%
8,548,596
-2.7%
0.01%
-8.3%
Q1 2023$490,038,215
+59.7%
8,783,621
+4.3%
0.01%
+50.0%
Q4 2022$306,825,200
+30.2%
8,420,011
+1.8%
0.01%
+14.3%
Q3 2022$235,654,000
-33.5%
8,274,359
+5.7%
0.01%
-30.0%
Q2 2022$354,205,000
-39.8%
7,827,758
+1.2%
0.01%
-28.6%
Q1 2022$588,213,000
-47.7%
7,732,523
+2.4%
0.01%
-46.2%
Q4 2021$1,125,251,000
+1.6%
7,554,042
-0.7%
0.03%
-3.7%
Q3 2021$1,106,997,000
-20.1%
7,604,044
+7.4%
0.03%
-20.6%
Q2 2021$1,386,321,000
+17.3%
7,079,569
+8.4%
0.03%
+6.2%
Q1 2021$1,181,629,000
+34.9%
6,528,337
+5.5%
0.03%
+28.0%
Q4 2020$876,179,000
+18.0%
6,187,705
+3.9%
0.02%0.0%
Q3 2020$742,397,000
+110.0%
5,954,418
+50.4%
0.02%
+92.3%
Q2 2020$353,469,000
+422.9%
3,957,771
+264.9%
0.01%
+333.3%
Q1 2020$67,599,000
-15.0%
1,084,716
+4.0%
0.00%0.0%
Q4 2019$79,509,000
+116.9%
1,042,739
+43.3%
0.00%
+200.0%
Q3 2019$36,662,000727,4270.00%
Other shareholders
10X GENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Venrock Management VI, LLC 962,309$188,439,00095.08%
Foresite Capital Management II, LLC 1,753,528$343,376,00092.37%
Foresite Capital Management I, LLC 750,000$146,865,00088.53%
12 West Capital Management LP 1,922,000$376,366,00015.78%
Financial Consulate Inc. 141,258$27,661,0009.97%
FINANCIAL CONSULATE, INC 141,258$27,661,0009.97%
Meritech Capital Associates V L.L.C. 1,793,871$351,276,0007.51%
Andar Capital Management HK Ltd 51,000$9,987,0006.81%
JS Capital Management LLC 540,589$105,858,0005.12%
Renaissance Capital LLC 97,281$19,050,0003.01%
View complete list of 10X GENOMICS INC shareholders